Charles L. Loprinzi, M.D.

  1. Oncologist

Departamentos

Grupos especializados

Location

  1. Rochester, Minnesota

Idiomas

English

Charles L. Loprinzi, M.D., is a medical oncologist. In his clinical time he primarily cares for patients with breast cancer.

Much of his time over the past couple of decades has been used to conduct clinically-based research. Along this line, his primary research is related to cancer-related symptom control. He defines this as conducting trials which aim to try to prevent, and/or treat, and/or better understand symptoms related to cancer and/or cancer treatment. He has been intimately involved with over 100 trials related to this topic, mostly randomized, placebo-controlled trials. Many of these trials have dealt with the following areas:

  • Chemotherapy-induced peripheral neuropathy
  • Menopausal symptoms, such as hot flashes and vaginal symptoms, in women who do not want to take estrogen
  • Mucositis related to cancer therapy
  • Chemotherapy-associated anorexia/cachexia (appetite loss and/or weight loss)
  • Optimizing communication to help patients decide appropriate cancer therapy for themselves, when there are options

Dr. Loprinzi is a co-director of the Mayo Clinic Cancer Center's Cancer Prevention and Control (CPC) Program.

Rochester

Rochester, Minnesota

  1. 1984
    Fellow - Medical OncologyUniversity of Wisconsin Clinical Cancer Center
  2. 1982
    Resident - Internal MedicineMaricopa County General Hospital
  3. 1980
    Internship - Internal MedicineMaricopa County General Hospital
  4. 1979
    MDOregon Health and Science University
  5. 1975
    BSOregon State University

Certificaciones

  1. 1985
    Medical OncologyAmerican Board of Internal Medicine
  2. 1982
    Internal MedicineAmerican Board of Internal Medicine

Reconocimientos y distinciones

  1. 2018
    Distinguished Service AwardMultinational Assocation of Supportive Care in Cancer (MASCC)
  2. 2013
    Charles G. Moertel Memorial LectureshipDivison of Medical Oncology
  3. 2012
    Fellow of the American Society of Clinical OncologyAmerican Society of Clinical Oncology
  4. 2010
    Regis Professor of Breast Cancer ResearchMayo Endowed Professorship
  5. 2008
    Statesmanship AwardAmerican Society of Clinical Oncology
  6. 2006
    Vasomotor Symptoms Research AwardNorth American Menopause Society
  7. 2005
    Clinical Research AwardAssociation of Community Cancer Centers
  8. 2005
    Professor of Survivorship AwardSusan G. Komen Breast Cancer Foundation
  9. 2003
    Outstanding Service AwardCancerCare
  10. 2002
    Brinker Award for Scientific DistinctionKomen Foundation
  11. 2000
    Teacher of the YearDivision of Medical Oncology, Department of Oncology

Membresía en asociaciones profesionales

  1. 2016 - 2018
    Study Group ChairNeurological Complications, Multinational Association of Supportive Care in Cancer
  2. 2016 - present
    Selection CommitteeGiants of Cancer Care
  3. 2015 - 2021
    Associate EditorAmerican Society of Clinical Oncology, Cancer.net Editorial Board
  4. 2015 - 2019
    Advisory Group MemberAmerican Society of Clinical Oncology, Supportive Care Guideline
  5. 2015
    MemberAmerican Society of Clinical Oncology, Guideline for the Prevention of Oral and Oro-pharyngeal Mucositis in Children Receiving Treatment for Cancer or Undergoing Hematopoietic Stem Cell Transplantation
  6. 2015
    MemberAmerican Society of Clinical Oncology, 2015 Palliative Care in Oncology Symposium Program Committee
  7. 2013 - 2019
    Executive Committee MemberExecutive Committee, Multinational Association of Supportive Care in Cancer
  8. 2013 - 2015
    EditorAmerican Society of Clinical Oncology, SEP Edition
  9. 2013 - 2014
    MemberMASCC Miami Meeting Scientific Committee, Multinational Association of Supportive Care in Cancer
  10. 2013 - present
    MemberNominations Committee, Multinational Association of Supportive Care in Cancer
  11. 2012
    Co-ChairChemotherapy-Induced Neuropathy Guideline Committee, American Society of Clinical Oncology
  12. 2012 - 2020
    Board of DirectorsMultinational Association of Supportive Care in Cancer, Board of Directors
  13. 2012 - 2013
    Immediate Past ChairEducation Products Subcommittee, American Society of Clinical Oncology
  14. 2012 - 2013
    MemberAmerican Society of Clinical Oncology, Integrated Media and Technology Committee
  15. 2011 - 2021
    ChairAlliance for Clinical Trials in Oncology, Symptom Intervention Committee
  16. 2011 - 2013
    EditorAmerican Society of Clinical Oncology, SEP Edition
  17. 2011 - 2012
    ChairEducation Products Subcommittee, American Society of Clinical Oncology
  18. 2011 - 2012
    Co-ChairAmerican Society of Clinical Oncology, Integrated Media and Technology Committee
  19. 2011 - present
    MemberAlliance for Clinical Trials in Oncology, Cancer Control Committee
  20. 2011 - present
    Vice ChairAcademic and Community Cancer Research United (ACCRU)
  21. 2011 - present
    ChairAcademic and Community Cancer Research United (ACCRU) Cancer Control
  22. 2010 - 2011
    Chair-ElectEducation Products Subcommittee, American Society of Clinical Oncology
  23. 2009 - 2015
    Study Group ChairNeurological Complications, Multinational Association of Supportive Care in Cancer
  24. 2009
    Section ChairSan Antonio Breast Cancer Symposium Program Scheduling Committee, Symptom Control
  25. 2009 - present
    MemberMultinational Association of Supportive Care in Cancer
  26. 2007 - present
    Steering CommitteeNational Institutes of Health, Symptom Management QOL
  27. 2007 - 2012
    MemberEducation Committee, American Society of Clinical Oncology
  28. 2006
    Grant ReviewerNIH Avon-NCI Progress for Patients Review
  29. 2006 - 2009
    MemberMembership Committee, American Society of Clinical Oncology
  30. 2006
    ChairSusan G. Komen Breast Cancer Foundation, Breast Health Advisory Council
  31. 2005 - 2008
    Associate EditorAmerican Society of Clinical Oncology, SEP Edition
  32. 2005 - 2006
    MemberBoard of Directors, Society of Integrative Oncology
  33. 2005
    MemberWomen's Healthcare Council, Mayo Clinic Rochester Committees
  34. 2005 - present
    MemberAmerican Society of Clinical Oncology, Roster of Cancer Experts
  35. 2004 - 2006
    MemberProgram Committee, Society of Integrative Oncology
  36. 2004 - 2006
    MemberBreast Subcommittee, Program Committee, American Society of Clinical Oncology
  37. 2004 - 2005
    ChairBylaws Committee, Society of Integrative Oncology
  38. 2004
    Founding MemberSociety of Integrative Oncology
  39. 2003
    MemberReview Committee, Innovative Cancer Complementary and Alternative Medicine Initiative in Cancer Centers, National Cancer Institute
  40. 2003 - 2007
    Selection CommitteeSusan G. Komen Breast Cancer Foundation, Brinker Award
  41. 2003 - 2005
    MemberSusan G. Komen Breast Cancer Foundation, Breast Health Advisory Council
  42. 2002 - 2005
    MemberNominating Committee, American Society of Clinical Oncology
  43. 2002 - 2004
    Associate EditorAmerican Society of Clinical Oncology, SEP Edition
  44. 2001 - 2005
    MemberBreast Practice Marketing Task Force, Mayo Clinic Rochester Task Forces
  45. 2001 - 2004
    ChairSusan G. Komen Breast Cancer Foundation, CAM Grant Review
  46. 2001 - 2002
    MemberPain and Symptom Management Subcommittee, American Society of Clinical Oncology
  47. 2000 - 2003
    MemberVoluntary Review Board, Physician Data Query Protocols, National Cancer Institute
  48. 2000 - 2002
    MemberGrants Selection Committee, American Society of Clinical Oncology
  49. 1999
    MemberPrevention, Detection, and Control Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  50. 1999 - 2003
    MemberDevelopment Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  51. 1999 - 2000
    ChairAmerican Society of Clinical Oncology, Program Committee, Symptom Management Subcommittee
  52. 1999 - present
    Co-LeaderPrevention, Detection, and Control Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  53. 1998 - 2000
    MemberProgram Committee, American Society of Clinical Oncology
  54. 1997 - 1999
    MemberAntiemetic Hospital Formulary Advisory Group, Mayo Clinic Rochester Workgroups
  55. 1997 - 1998
    MemberMedical Advisory Board, National Lymphedema Network
  56. 1997 - 1998
    External Grant ReviewerNational Institute of Canada
  57. 1996 - 2003
    ChairAdministrative Committee, Division of Medical Oncology, Department of Oncology
  58. 1996 - 1999
    MemberDirector's Advisory Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  59. 1996 - 2003
    MemberSearch Committee for Clinician Investigators, Division of Medical Oncology, Department of Oncology
  60. 1996
    Expert Panel MemberColorectal Cancer Follow-Up Diagnostic Testing Expert Panel, American Society of Clinical Oncology
  61. 1995 - 2005
    MemberData Monitoring and Patient Safety Committee, Women's Healthy Eating and Living Study
  62. 1995 - 1999
    MemberClinical Research Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  63. 1995
    MemberWork Group on Economic Analyses on Phase III Clinical Trials, American Society of Clinical Oncology
  64. 1994 - 2001
    MemberPhysician Practice Committee, Division of Medical Oncology, Department of Oncology
  65. 1994 - 1996
    ChairPhysician Practice Committee, Division of Medical Oncology, Department of Oncology
  66. 1994 - 1999
    MemberAdministrative Committee, Department of Internal Medicine
  67. 1994 - 1996
    ChairChemotherapy Costs Committee, Mayo Clinic Rochester Committees
  68. 1994 - 1995
    MemberMedical Specialties Task Force, Mayo Clinic Rochester Task Forces
  69. 1993
    MemberAd Hoc Grant Review Committee, National Cancer Institute, National Institutes of Health
  70. 1993 - 1994
    MemberInternal Medicine Practice Committee, Department of Internal Medicine
  71. 1993 - 1994
    ChairClinical Practice Committee, Division of Medical Oncology, Department of Oncology
  72. 1992
    MemberBillings, Montana, Site Visit, North Central Cancer Treatment Group/Eastern Cooperative Oncology Group
  73. 1991
    MemberRegina, Saskatchewan, Site Visit, North Central Cancer Treatment Group
  74. 1991
    MemberSaskatoon, Saskatchewan, Site Visit, North Central Cancer Treatment Group
  75. 1991
    MemberOschner Clinic, Site Visit, North Central Cancer Treatment Group/Eastern Cooperative Oncology Group
  76. 1991 - 2011
    Program DirectorCancer Control, North Central Cancer Treatment Group
  77. 1991 - 1996
    MemberCancer Prevention and Control Committee, American Society of Clinical Oncology
  78. 1991 - 1992
    MemberProgram Committee, American Society of Clinical Oncology
  79. 1990
    MemberWorkshop on Cancer Pain, National Cancer Institute, National Institutes of Health
  80. 1990
    MemberWorkshop on Quality of Life in Cancer Clinical Trials, National Cancer Institute, National Institutes of Health
  81. 1989
    MemberBillings, Montana, Site Visit, North Central Cancer Treatment Group
  82. 1989
    MemberBismarck, North Dakota, Site Visit, North Central Cancer Treatment Group
  83. 1989 - 1990
    MemberExternal Advisory Committee, Northern California Cancer Center
  84. 1989
    MemberAd Hoc Technical Review Panel, National Cancer Institute, National Institutes of Health
  85. 1988
    MemberRegina, Saskatchewan, Site Visit, North Central Cancer Treatment Group
  86. 1988
    MemberSaskatoon, Saskatchewan, Site Visit, North Central Cancer Treatment Group
  87. 1988
    MemberAd Hoc Committee for Review of R01 Applications, National Institutes of Health
  88. 1987
    MemberGeisinger Clinic, Site Visit, North Central Cancer Treatment Group/Eastern Cooperative Oncology Group
  89. 1987 - present
    MemberExecutive Committee, North Central Cancer Treatment Group
  90. 1986 - 2011
    Scientific CoordinatorNorth Central Critical Care Society, Cancer Control Studies
  91. 1986
    MemberLocally Advanced Breast Cancer Strategy Committee, National Cancer Institute, National Institutes of Health
  92. 1986 - present
    MemberClinical Practice Committee, Division of Medical Oncology, Department of Oncology
  93. 1985 - 1987
    MemberBreast Cancer Steering Committee, Eastern Cooperative Oncology Group
  94. 1985 - 1986
    MemberCancer Prevention Committee, Minnesota Division, American Cancer Society
  95. 1985 - present
    MemberAmerican Society of Preventive Oncology
  96. 1985 - present
    MemberMinnesota Medical Association
  97. 1984 - 1985
    MemberWisconsin Clinical Cancer Center, Cancer Prevention Committee
  98. 1984 - 1985
    MemberWisconsin Clinical Cancer Center, Clinical Affairs Committee
  99. 1984 - 1985
    MemberWisconsin Clinical Cancer Center, Human Oncology Library Committee
  100. 1984 - 1985
    Study GroupWisconsin Clinical Cancer Center, Lung Cancer
  101. 1983 - 1985
    Working Group MemberWisconsin Clinical Cancer Center, Urologic Oncology
  102. 1981 - 1982
    PresidentMaricopa County General Hospital, Internal Medicine Resident Group
  103. 1981 - 1982
    MemberMaricopa County General Hospital, Pharmacy and Therapeutics Committee
  104. 1981 - 1982
    MemberMaricopa County General Hospital, Intern Selection Committee
  105. 1981 - 1982
    CoordinatorMaricopa County General Hospital, Nurse Appreciation Week
  106. 1980 - 1981
    MemberMaricopa County General Hospital, Cost Containment Committee
  107. 1980 - present
    MemberAmerican Medical Association
  108.  
    MemberZumbro Valley Medical Society, Minnesota Medical Association
  109.  
    MemberSigma Xi, The Scientific Research Society